Breast AI

Arterys

Breast AI provides solutions for breast cancer detection, measure breast density and assess personalized risk that are aimed at to optimizing efficiency, enhancing the patient experience, and improving outcomes. Arterys' Breast AI solution incorporates algorithms developed by iCAD and Therapixel.

Product specifications

Information source: Vendor
Last updated: Nov. 2, 2022

General
Product name	Breast AI
Company	Arterys
Subspeciality	Breast
Modality	Mammography
Disease targeted	Breast cancer
Key-features	Lesion detection, segmentation, breast cancer risk estimation, automated breast density assessment
Suggested use	Before: adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion After: diagnosis verification
Data characteristics
Population	Women at any age
Input	2D full field digital mammogram, 3D digital tomosynthesis, 2D synthetic, 3D slabs
Input format	DICOM
Output	Density score assessment, lesion segmentation, risk score
Output format	DICOM SC, SR, GSPS
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application
Deployment	Cloud-based
Trigger for analysis	Automatically, right after the image acquisition
Processing time	1 - 10 minutes
Certification
CE	Certified, Class IIa , MDD/MDR
FDA	510(k) cleared, Class II
Market presence
On market since	05-2022
Distribution channels
Countries present (clinical, non-research use)	5
Paying clinical customers (institutes)	10
Research/test users (institutes)	10
Pricing
Pricing model	Pay-per-use
Based on	Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers